Date: 2016-03-24
Type of information: Resignation
Compound:
Company: 4SC (Germany)
Therapeutic area: Cancer - Oncology
Type agreement: resignation
Action mechanism:
Disease:
Details: * On March 24, 2016, 4SC announced that the Chairman of its Management Board, Enno Spillner, informed 4SC’s Supervisory Board that he will not accept the recently received offer to extend his current term of office ending 31 March 2016. However, Enno Spillner will continue to be at the Company’s disposal as Chairman of the Management Board for a transitional period ending 30 June 2016.
Financial terms:
Latest news:
